• Eliminating cervical cancer: How it could be done

    Cervical cancer is one of the most preventable cancers, but too few young women are vaccinated against HPV infections. The WHO wants to take action against this with a worldwide strategy.

  • Therapy of ovarian cancer: What is the significance of PARP inhibitors?

    Studies show PARP inhibitors can also be used earlier in the course of recurrent ovarian cancer.

  • What drives breast cancer metastases?

    What do we know today about the formation and development of breast cancer metastases? Experts from Pittsburgh and Heidelberg addressed this issue at the 11th Charité-Mayo Conference.

  • Cancer, art and culture: Kool Savas performs at the 2021 International Charité Mayo Conference

    German rap legend Kool Savas and singer Alies performed the track "AMG" at the 11th ICMC. The message: Believe in yourself.

  • Three pillars for recurrent ovarian cancer treatment

    In recurrent ovarian cancer, oncologists rely on surgery, chemotherapy and maintenance therapy. At the 11th ICMC, experts from Charité and Mayo Clinic explained how such regimes interact.

  • Therapy of recurrent ovarian cancer

    Today, the therapy for recurrent ovarian cancer is determined by numerous factors. Unlike in earlier times, the length of platinum-free therapy intervals plays only a subordinate role.

  • International Charité Mayo Conference 2021: The future of cancer treatment methods for women

    Between 5-8 May 2021, experts from various fields will meet online for the 11th international Charité Mayo Conference under the motto "Global Perspectives and Future Directions in Women's Cancer"